California-based Masimo Corporation is a global leader in the development, manufacturing and marketing of advanced patient monitoring technologies, automation and connectivity solutions. Boasting a diverse portfolio of products, the company's offerings are designed to address the limitations of conventional pulse oximetry and include the revolutionary Masimo Signal Extraction Technology (SET) Pulse Oximetry, which features measure-through motion and low perfusion pulse oximetry monitoring. Additionally, the company's Rainbow SET Platform delivers noninvasive monitoring of critical physiological parameters, including carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, and respiration and pleth variability index. With solutions ranging from brain function monitoring, patient position tracking, neuromodulation, respiratory gas monitoring and telehealth, Masimo Corporation is dedicated to enabling healthcare providers to deliver best-in-class patient care. The company distributes its products through a mix of direct sales forces, as well as partnerships with distributors and original equipment manufacturers across the globe. Masimo Corporation was founded in 1989 and is located in Irvine, California.